TipRanks
Go Ultimate55% OFF

Jason Haas Insider Profile

11 Followers

Jason Haas, Director at Ligand Pharma, holds 3.98K shares in Ligand Pharma (Ticker: LGND), holds 62.91K shares in Odyssey Therapeutics, Inc. (Ticker: ODTX), holds 0.00 shares in Syros Pharmaceuticals (Ticker: SYRS).

Jason Haas's Trading History

LGND
Ligand Pharma
Aug 14, 2026DirectorUninformative Buy316.48K$1.28M
ODTX
Odyssey Therapeutics, Inc.
May 11, 2026Chief Financial OfficerInformative Buy20.00K$1.23M
SYRS
Syros Pharmaceuticals
Nov 20, 2024CFOInformative Sell28.94K―

You May Also Like

Jason Haas insider profile FAQ

What is the percentage of profitable transactions made by Jason Haas?
The percentage of profitable transactions made by Jason Haas is 25%.
What is the average return per transaction made by Jason Haas?
The average return per transaction made by Jason Haas is -26.60%.
What stocks does Jason Haas hold?
Jason Haas holds: LGND, SYRS, ODTX stocks.
What was Jason Haas’s latest transaction?
Jason Haas’s latest transaction was an Uninformative Buy of $316.48K.
What was Jason Haas's most profitable transaction?
Jason Haas’s most profitable transaction was an Informative Buy of ODTX stock on May 11, 2026. The return on the trade was 11.90%.
What is Jason Haas's role in Ligand Pharma?
Jason Haas's role in Ligand Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.